Tsukuba, Japan

Osamu Ohmori



 

Average Co-Inventor Count = 8.9

ph-index = 4

Forward Citations = 104(Granted Patents)


Location History:

  • Ibaraki, JP (2012)
  • Tsukuba, JP (2011 - 2013)
  • Shizuoka, JP (2012 - 2013)
  • Izunokuni, JP (2014)

Company Filing History:

goldMedal7 out of 3,923 
 
Novartis Ag
 patents
silverMedal1 out of 151 
 
Irm LLC
 patents
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Osamu Ohmori

Introduction

Osamu Ohmori is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of organic compounds and medicinal chemistry. With a total of 8 patents to his name, Ohmori's work has had a considerable impact on the development of treatments for various disorders.

Latest Patents

One of his latest patents involves organic compounds that serve as inhibitors of CETP. This invention provides a compound of formula (I), wherein the variants R1, R2, R3, R4, R6, and R7 are defined, and the compound can be employed for treating disorders mediated by CETP. Another significant patent focuses on 2,4-diaminopyrimidine derivatives, which are useful in disorders where ZAP-70 and/or Syk inhibition plays a role, particularly those caused by malfunctions in signal cascades connected with FAK.

Career Highlights

Throughout his career, Osamu Ohmori has worked with prominent companies such as Novartis AG and Irm LLC. His innovative research has contributed to advancements in pharmaceutical sciences and therapeutic applications.

Collaborations

Ohmori has collaborated with notable colleagues, including Naoko Matsuura and Ichiro Umemura. These partnerships have fostered a collaborative environment that enhances the development of new inventions.

Conclusion

Osamu Ohmori's contributions to the field of organic compounds and medicinal chemistry highlight his role as a significant inventor. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…